Mark J. Rosenblum, Executive VP Finance, CFO at Salarius Pharmaceuticals, Inc. (SLRX), bought 20,000 shares at $0.80 ($16K) on 2025-11-20, disclosed to the SEC on 2025-11-20.
Seasonal purchase ($16k) by Executive VP Finance, CFO — this insider has traded SLRX in November in at least three consecutive prior years. Pattern-driven, low signal.
Something here stands out, but not much.
| Filing → |
| SLRX | BUY | 2020-08-18 | $5K | — | Filing → |
| SLRX | BUY | 2020-02-20 | $2K | — | Filing → |
| SLRX | BUY | 2020-02-13 | $4K | — | Filing → |